Chordoma Characterization of Significant Changes of the DNA Methylation Pattern

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Rinner, Beate ^a   Weinhaeusel, Andreas ^b   Lohberger, Birgit ^a   Froehlich, Elke Verena ^a   Pulverer, Walter ^b   Fischer, Carina ^a   Meditz, Katharina ^a   Scheipl, Susanne ^a   Trajanoski, Slave ^a   Guelly, Christian ^a   Leithner, Andreas ^a   Liegl, Bernadette ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b AIT AUSTRIAN INSTITUTE OF TECHNOLOGY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3; FRAGILE X MENTAL RETARDATION PROTEIN; KLOTHO PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; RETINOIC ACID RECEPTOR BETA; TUMOR MARKER;

ADULT; AGED; ARTICLE; C3 GENE; CARCINOGENESIS; CHORDOMA; CLINICAL ARTICLE; CONTROLLED STUDY; COPY NUMBER VARIATION; CPG ISLAND; DLEC1 GENE; DNA DETERMINATION; DNA METHYLATION; EPIGENETICS; FEMALE; FMR1 GENE; GENE LOSS; GENETIC GAIN; GENETIC MARKER; GENETIC SCREENING; GENOMIC INSTABILITY; HUMAN; HUMAN TISSUE; HYPERMETHYLATED IN CANCER 1 GENE; KLOTHO GENE; MALE; MOLECULAR PATHOLOGY; ONCOGENE; POLYMERASE CHAIN REACTION; RARB GENE; RAS ASSOCIATION DOMAIN FAMILY 1 PROTEIN GENE; SINGLE NUCLEOTIDE POLYMORPHISM; TACSTD2 GENE; XIST GENE;

ADULT; AGED; ANTIGENS, NEOPLASM; CELL ADHESION MOLECULES; CHORDOMA; DNA METHYLATION; FEMALE; FRAGILE X MENTAL RETARDATION PROTEIN; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTORS, RETINOIC ACID; RNA, LONG UNTRANSLATED; TUMOR SUPPRESSOR PROTEINS;

EID: 84875294764     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0056609     Document Type: Article

References (34)

1. Chugh R, Tawbi H, Lucas DR, Biermann JS, Schuetze SM, et al. (2007) Chordoma: the nonsarcoma primary bone tumor. Oncologist 12: 1344-1350.
2. Fletcher CD, Mertens F, Unni KK (2002) Pathology and Genetics of Tumours of Soft Tissue and Bone Vol. 5: World Health Organization Classification of Tumours.
3. Catton C, O'Sullivan B, Bell R, Laperriere N, Cummings B, et al. (1996) Chordoma: long-term follow-up after radical photon irradiation. Radiother Oncol 41: 67-72.
4. Hallor KH, Staaf J, Jonsson G, Heidenblad M, Vult von Steyern F, et al. (2008) Frequent deletion of the CDKN2A locus in chordoma: analysis of chromosomal imbalances using array comparative genomic hybridisation. Br J Cancer 98: 434-442.
5. Dhe-Paganon S, Syeda F, Park L, (2011) DNA methyl transferase 1: regulatory mechanisms and implications in health and disease. Int J Biochem Mol Biol 2: 58-66.
6. Ransohoff DF, (2003) Developing molecular biomarkers for cancer. Science 299: 1679-1680.
7. Herman JG, Baylin SB, (2003) Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 349: 2042-2054.
8. Weinhaeusel A, Thiele S, Hofner M, Hiort O, Noehammer C, (2008) PCR-based analysis of differentially methylated regions of GNAS enables convenient diagnostic testing of pseudohypoparathyroidism type Ib. Clin Chem 54: 1537-1545.
9. Weinhaeusel A, Thiele S, Hofner M, Hiort O, Noehammer C, (2008) PCR-based analysis of differentially methylated regions of GNAS enables convenient diagnostic testing of pseudohypoparathyroidism type Ib. Clin Chem 54: 1537-1545.
10. Wright GW, Simon RM, (2003) A random variance model for detection of differential gene expression in small microarray experiments. Bioinformatics 19: 2448-2455.
11. Simon R, Lam A, Li MC, Ngan M, Menenzes S, et al. (2007) Analysis of gene expression data using BRB-ArrayTools. Cancer Inform 3: 11-17.
12. Le LP, Nielsen GP, Rosenberg AE, Thomas D, Batten JM, et al. (2011) Recurrent chromosomal copy number alterations in sporadic chordomas. PLoS One 6: e18846.
13. Dalpra L, Malgara R, Miozzo M, Riva P, Volonte M, et al. (1999) First cytogenetic study of a recurrent familial chordoma of the clivus. Int J Cancer 81: 24-30.
14. Scheil S, Bruderlein S, Liehr T, Starke H, Herms J, et al. (2001) Genome-wide analysis of sixteen chordomas by comparative genomic hybridization and cytogenetics of the first human chordoma cell line, U-CH1. Genes Chromosomes Cancer 32: 203-211.
15. Naumann RW, (2011) The role of the phosphatidylinositol 3-kinase (PI3K) pathway in the development and treatment of uterine cancer. Gynecol Oncol 123: 411-420.
16. Chang CC, Ye BH, Chaganti RS, Dalla-Favera R, (1996) BCL-6, a POZ/zinc-finger protein, is a sequence-specific transcriptional repressor. Proc Natl Acad Sci USA 93: 6947-6952.
17. Vasanwala FH, Kusam S, Toney LM, Dent AL, (2002) Repression of AP-1 function: a mechanism for the regulation of Blimp-1 expression and B lymphocyte differentiation by the B cell lymphoma-6 protooncogene. J Immunol 169: 1922-1929.
18. Chamdin A, Jarzembowski JA, Subramanian C, Kuick R, Lee JS, et al. (2009) Bcl6 is expressed in neuroblastoma: tumor cell type-specific expression predicts outcome. Transl Oncol 2: 128-137.
19. Cavenee WK, (1991) Charles S. Mott Prize. Recessive mutations in the causation of human cancer. Cancer 67: 2431-2435.
20. Agathanggelou A, Cooper WN, Latif F, (2005) Role of the Ras-association domain family 1 tumor suppressor gene in human cancers. Cancer Res 65: 3497-3508.
21. Agrawal A, Murphy RF, Agrawal DK, (2007) DNA methylation in breast and colorectal cancers. Mod Pathol 20: 711-721.
22. Lehmann U, Langer F, Feist H, Glockner S, Hasemeier B, et al. (2002) Quantitative assessment of promoter hypermethylation during breast cancer development. Am J Pathol 160: 605-612.
23. Kurosu H, Kuro-o M, (2008) The Klotho gene family and the endocrine fibroblast growth factors. Curr Opin Nephrol Hypertens 17: 368-372.
24. Wang YA, (2006) Klotho, the long sought-after elixir and a novel tumor suppressor? Cancer Biol Ther 5: 20-21.
25. Sommer J, Itani DM, Homlar KC, Keedy VL, Halpern JL, et al. (2010) Methylthioadenosine phosphorylase and activated insulin-like growth factor-1 receptor/insulin receptor: potential therapeutic targets in chordoma. J Pathol 220: 608-617.
26. Scheipl S, Froehlich EV, Leithner A, Beham A, Quehenberger F, et al. (2012) Does insulin-like growth factor 1 receptor (IGF-1R) targeting provide new treatment options for chordomas? A retrospective clinical and immunohistochemical study. Histopathology 60: 999-1003.
27. Wolf I, Levanon-Cohen S, Bose S, Ligumsky H, Sredni B, et al. (2008) Klotho: a tumor suppressor and a modulator of the IGF-1 and FGF pathways in human breast cancer. Oncogene 27: 7094-7105.
28. Kurosu H, Yamamoto M, Clark JD, Pastor JV, Nandi A, et al. (2005) Suppression of aging in mice by the hormone Klotho. Science 309: 1829-1833.
29. Kuro-o M, Matsumura Y, Aizawa H, Kawaguchi H, Suga T, et al. (1997) Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 390: 45-51.
30. Wales MM, Biel MA, El Deiry W, Nelkin BD, Issa JP, et al. (1995) p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3. Nat Med 1: 570-577.
31. Weinhaeusel A, Noehammer C (2009) Methylation Assay. European Patent Application EP 09450020.4. filed 26-1-2009; WO2010086389 A1 (2010-08-05).
32. Neumann L, Weinhäusel A, Thomas S, Horsthemke B, Lohmann DR, et al. (2011) EFS shows biallelic methylation inuveal melanoma with poor prognosis as well as tissue-specific methylation. BMC Caner 11: 380-391.
33. Weinhaeusel A (2010) Lung Cancer Methylation Markers. PCT-Application PCT/EP2010/051032. filed 28-1-2010. WO2010086388 A1 (2010-08-05).
34. Nikolaidis G, Raji OY, Markopoulou S, Gosney JR, Bryan J, et al. (2012) DNA methylation biomarkers offer improved diagnostic efficiency in lung cancer. Cancer Res 72(22): 5692-701 doi:10.1158/0008-5472.CAN-12-2309. Epub 2012 Sep 7.